AO

Active Director Director DIN 08210732
DIN 08210732 First appointment Aug 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2018
Shareholding value •••• Premium profile

About Arti Ojha

Data last updated:

Arti Ojha is a Director at Incredible Pharmaceutical Private Limited (since 2018). The company operates in Pharma. Incredible Pharmaceutical Private Limited reported revenue of ₹10.9 Lakh (FY 2022).

DIN 08210732
Primary Designation Director
Industry Pharma
First Appointment 30 Aug 2018
Oldest Company Age 8 yrs
Largest company Incredible Pharmaceutical Private Limited · ₹10.9 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Aug 20182018₹10.9 Lakh (FY 2022)Active

Board colleagues of Arti Ojha

NameDINCompanyDesignation
Gaurav Raj Sharma08210731Incredible Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Incredible Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Arti Ojha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arti Ojha

Arti Ojha currently holds 1 directorship: Incredible Pharmaceutical Private Limited (Director, since 30 Aug 2018, revenue ₹10.9 Lakh (FY 2022)).

Arti Ojha was first appointed on 30 Aug 2018 as Director at Incredible Pharmaceutical Private Limited.

The current boards of Arti Ojha's companies include Gaurav Raj Sharma (Incredible Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available